Drs. Stephen Rennard and Shawn Aaron discuss a manuscript from Dr. Rennard and his colleagues about using the CXCR2 antagonist MK-7123 to improve lung function in COPD. The podcast is moderated by AJRCCM podcast editor, Nitin Seam.

Phase 2 Trial of a Novel COPD Treatment

The Out of the Blue podcast takes you out of the pages of the American Journal of Respiratory and Critical Care Medicine and into the minds of the most brilliant researchers in the fields of respiratory, critical care, and sleep medicine.

Share Phase 2 Trial of a Novel COPD Treatment

Sign up to save your podcasts

Phase 2 Trial of a Novel COPD Treatment

Phase 2 Trial of a Novel COPD Treatment

More shows like Out of the Blue: An AJRCCM Podcast

EMCrit FOAM Feed

JAMA Editors' Summary

NEJM This Week

JAMA Clinical Reviews

CHEST Journal Podcasts

ATS Breathe Easy

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

Annals On Call Podcast

The Internet Book of Critical Care Podcast

JAMA Medical News

Run the List

Critical Care Scenarios

The Curious Clinicians

Critical Care Time